Russia’s Defense Ministry on Monday laid out more evidence that US-funded laboratories were working in Ukraine. Documents and materials recovered by Russian troops showed that Western pharmaceutical companies operating in territory under Kiev’s control conducted HIV/AIDS research on Ukrainian military personnel.
The commander of Russia’s Nuclear, Biological and Chemical Defense Forces, Lieutenant General Igor Kirillov, presented Ukrainian-language documents referring to HIV infection studies that began in 2019. The list of targeted groups shows service members alongside prisoners, drug addicts and other “patients at high risk of infection.”
According to Kirillov, the Russian military has recovered more than 20,000 documents and other materials related to the biological programs in Ukraine, while interviewing eyewitnesses and participants. The evidence “confirms the focus of the Pentagon on creating biological weapons components and testing them on the population of Ukraine and other states along [Russia’s] borders,” the general told reporters.
Based on documents originating with the Pentagon’s Defense Threat Reduction Agency (DTRA), the Russian military identified eight more individuals involved in the US-funded research in Ukraine. Among the names Kirillov singled out was Karen Saylors of Labyrinth Global Health, previously of Metabiota, a company linked to US President Joe Biden’s son Hunter.